COVID-19 positivity lower for some with psychiatric disorders

COVID-19 positivity lower for some with psychiatric disorders

(HealthDay)—Patients with psychiatric disorders, including schizophrenia and mood disorders, are less likely to test positive for COVID-19, but have increased COVID-19 mortality, according to a study published online Nov. 23 in JAMA Network Open.

Antonio L. Teixeira, M.D., Ph.D., from the University of Texas Health Science Center at Houston, and colleagues assessed the odds of testing positive for and mortality from COVID-19 among and between patients with schizophrenia, , anxiety disorders, and a reference group with no major psychiatric conditions. A total of 2,535,098 unique individuals were included in the population studied, of whom 3,350 had schizophrenia, 26,610 had mood disorders, and 18,550 had anxiety disorders.

The researchers found that rate of testing positive for COVID-19 in 2020 was significantly lower for the schizophrenia cohort and the mood disorder cohort than the anxiety disorder cohort (9.86 and 9.86 percent, respectively, versus 11.17 percent; odds ratios, 0.90 and 0.93, respectively), which was closer to the reference group (11.91 percent). Compared with the reference group, patients with schizophrenia were nearly four times more likely to die from COVID-19 after fully adjusting for demographic factors and comorbid conditions (odds ratio, 3.74). The odds of mortality were also increased for the mood COVID-19 cohort and cohort (odds ratios, 2.76 and 2.39, respectively).

"This 's findings suggest the need to foster recognition of pandemic risks on specific groups of patients with psychiatric conditions, and may drive alternative approaches to COVID-19 disease testing and interventions to improve clinical outcomes," the authors write.

One author disclosed financial ties to the biopharmaceutical industry.

More information: Abstract/Full Text

Journal information: JAMA Network Open

Copyright © 2021 HealthDay. All rights reserved.

Citation: COVID-19 positivity lower for some with psychiatric disorders (2021, November 23) retrieved 23 July 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Schizophrenia tied to higher risk for severe COVID-19


Feedback to editors